Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1072355

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1072355

LAMEA Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type (Proliferative and Diabetic Macular Edema (DME)), By Treatment Type, By Country and Growth Forecast, 2021 - 2027

PUBLISHED:
PAGES: 71 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Diabetic Retinopathy Market would witness market growth of 14.6% CAGR during the forecast period (2021-2027).

Surgical tools have been majorly improved in terms of precision and accuracy, due to which, the success rate of surgeries and operations is constantly increasing. As a result, the availability of such advanced ophthalmic equipment and systems has enabled medical and treatment operations. Due to this, patients are becoming less hesitant to this treatment alternative. Moreover, an increasing number of people who are becoming aware of the efficiency of the diabetic retinopathy surgery. This factor is considerably propelling the growth of the diabetic retinopathy market all over the region.

The Middle Eastern population is rapidly aging, and because age is a major risk factor for the occurrence of cancer, the frequency, and prevalence of the disease are rising across the region. National, as well as community-based health services, face significant problems as a result of these developments. Most Middle Eastern countries, given their current condition of affairs, require international support to deal with such new problems in their health systems. The training and education of professionals, namely physicians and nurses, in the primary, secondary, and tertiary stages of health services is the focus and priority in dealing with these changing situations. The growing focus of healthcare facilities, as well as government organizations along with research institutes, would majorly drive the demand for the diabetic retinopathy treatment across the region.

The Brazil market dominated the LAMEA Diabetic Retinopathy Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $127.4 Million by 2027. The Argentina market is estimated to witness a CAGR of 15.2% during (2021 - 2027). Additionally, The UAE market would experience a CAGR of 14.3% during (2021 - 2027).

Based on Type, the market is segmented into Proliferative and Diabetic Macular Edema (DME). Based on Treatment Type, the market is segmented into Anti VEGF Drug, Steroid Implants, Laser Surgeries, and Vitrectomy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC (Abbvie, Inc.), Bayer AG, Alimera Sciences, Inc., Novartis AG, Pfizer, Inc., F-Hoffmann-La Roche Ltd., Ampio Pharmaceuticals-us, KOWA CO., LTD., Regeneron Pharmaceuticals, Inc., and Bausch Health Companies, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Proliferative
  • Diabetic Macular Edema (DME)

By Treatment Type

  • Anti VEGF Drug
  • Steroid Implants
  • Laser Surgeries
  • Vitrectomy

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Allergan PLC (Abbvie, Inc.)
  • Bayer AG
  • Alimera Sciences, Inc.
  • Novartis AG
  • Pfizer, Inc.
  • F-Hoffmann-La Roche Ltd.
  • Ampio Pharmaceuticals-us
  • KOWA CO., LTD.
  • Regeneron Pharmaceuticals, Inc.
  • Bausch Health Companies, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Diabetic Retinopathy Market, by Type
    • 1.4.2 LAMEA Diabetic Retinopathy Market, by Treatment Type
    • 1.4.3 LAMEA Diabetic Retinopathy Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Diabetic Retinopathy Market

Chapter 4. LAMEA Diabetic Retinopathy Market by Type

  • 4.1 LAMEA Proliferative Market by Country
  • 4.2 LAMEA Diabetic Macular Edema (DME) Market by Country

Chapter 5. LAMEA Diabetic Retinopathy Market by Treatment Type

  • 5.1 LAMEA Anti VEGF Drug Market by Country
  • 5.2 LAMEA Steroid Implants Market by Country
  • 5.3 LAMEA Laser Surgeries Market by Country
  • 5.4 LAMEA Vitrectomy Market by Country

Chapter 6. LAMEA Diabetic Retinopathy Market by Country

  • 6.1 Brazil Diabetic Retinopathy Market
    • 6.1.1 Brazil Diabetic Retinopathy Market by Type
    • 6.1.2 Brazil Diabetic Retinopathy Market by Treatment Type
  • 6.2 Argentina Diabetic Retinopathy Market
    • 6.2.1 Argentina Diabetic Retinopathy Market by Type
    • 6.2.2 Argentina Diabetic Retinopathy Market by Treatment Type
  • 6.3 UAE Diabetic Retinopathy Market
    • 6.3.1 UAE Diabetic Retinopathy Market by Type
    • 6.3.2 UAE Diabetic Retinopathy Market by Treatment Type
  • 6.4 Saudi Arabia Diabetic Retinopathy Market
    • 6.4.1 Saudi Arabia Diabetic Retinopathy Market by Type
    • 6.4.2 Saudi Arabia Diabetic Retinopathy Market by Treatment Type
  • 6.5 South Africa Diabetic Retinopathy Market
    • 6.5.1 South Africa Diabetic Retinopathy Market by Type
    • 6.5.2 South Africa Diabetic Retinopathy Market by Treatment Type
  • 6.6 Nigeria Diabetic Retinopathy Market
    • 6.6.1 Nigeria Diabetic Retinopathy Market by Type
    • 6.6.2 Nigeria Diabetic Retinopathy Market by Treatment Type
  • 6.7 Rest of LAMEA Diabetic Retinopathy Market
    • 6.7.1 Rest of LAMEA Diabetic Retinopathy Market by Type
    • 6.7.2 Rest of LAMEA Diabetic Retinopathy Market by Treatment Type

Chapter 7. Company Profiles

  • 7.1 Alimera Sciences, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Partnerships, Collaborations, and Agreements:
      • 7.1.5.2 Geographical Expansions:
  • 7.2 F. Hoffmann-La Roche Ltd.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Partnerships, Collaborations, and Agreements:
      • 7.2.5.2 Approvals and Trials:
  • 7.3 Bausch Health Companies, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expense
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Partnerships, Collaborations, and Agreements:
      • 7.3.5.2 Approvals and Trials:
  • 7.4 Bayer AG
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Approvals and Trials:
  • 7.5 Pfizer, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional & Segmental Analysis
    • 7.5.4 Research & Development Expense
  • 7.6 Novartis AG
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
  • 7.7 Allergan PLC (AbbVie, Inc.)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Partnerships, Collaborations, and Agreements:
  • 7.8 Regeneron Pharmaceuticals, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Research & Development Expense
      • 7.8.3.1 Approvals and Trials:
  • 7.9 Ampio Pharmaceuticals, Inc.
    • 7.9.1 Company Overview
  • 7.10. Kowa Company, Ltd.
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 LAMEA Diabetic Retinopathy Market, 2017 - 2020, USD Million
  • TABLE 2 LAMEA Diabetic Retinopathy Market, 2021 - 2027, USD Million
  • TABLE 3 LAMEA Diabetic Retinopathy Market by Type, 2017 - 2020, USD Million
  • TABLE 4 LAMEA Diabetic Retinopathy Market by Type, 2021 - 2027, USD Million
  • TABLE 5 LAMEA Proliferative Market by Country, 2017 - 2020, USD Million
  • TABLE 6 LAMEA Proliferative Market by Country, 2021 - 2027, USD Million
  • TABLE 7 LAMEA Diabetic Macular Edema (DME) Market by Country, 2017 - 2020, USD Million
  • TABLE 8 LAMEA Diabetic Macular Edema (DME) Market by Country, 2021 - 2027, USD Million
  • TABLE 9 LAMEA Diabetic Retinopathy Market by Treatment Type, 2017 - 2020, USD Million
  • TABLE 10 LAMEA Diabetic Retinopathy Market by Treatment Type, 2021 - 2027, USD Million
  • TABLE 11 LAMEA Anti VEGF Drug Market by Country, 2017 - 2020, USD Million
  • TABLE 12 LAMEA Anti VEGF Drug Market by Country, 2021 - 2027, USD Million
  • TABLE 13 LAMEA Steroid Implants Market by Country, 2017 - 2020, USD Million
  • TABLE 14 LAMEA Steroid Implants Market by Country, 2021 - 2027, USD Million
  • TABLE 15 LAMEA Laser Surgeries Market by Country, 2017 - 2020, USD Million
  • TABLE 16 LAMEA Laser Surgeries Market by Country, 2021 - 2027, USD Million
  • TABLE 17 LAMEA Vitrectomy Market by Country, 2017 - 2020, USD Million
  • TABLE 18 LAMEA Vitrectomy Market by Country, 2021 - 2027, USD Million
  • TABLE 19 LAMEA Diabetic Retinopathy Market by Country, 2017 - 2020, USD Million
  • TABLE 20 LAMEA Diabetic Retinopathy Market by Country, 2021 - 2027, USD Million
  • TABLE 21 Brazil Diabetic Retinopathy Market, 2017 - 2020, USD Million
  • TABLE 22 Brazil Diabetic Retinopathy Market, 2021 - 2027, USD Million
  • TABLE 23 Brazil Diabetic Retinopathy Market by Type, 2017 - 2020, USD Million
  • TABLE 24 Brazil Diabetic Retinopathy Market by Type, 2021 - 2027, USD Million
  • TABLE 25 Brazil Diabetic Retinopathy Market by Treatment Type, 2017 - 2020, USD Million
  • TABLE 26 Brazil Diabetic Retinopathy Market by Treatment Type, 2021 - 2027, USD Million
  • TABLE 27 Argentina Diabetic Retinopathy Market, 2017 - 2020, USD Million
  • TABLE 28 Argentina Diabetic Retinopathy Market, 2021 - 2027, USD Million
  • TABLE 29 Argentina Diabetic Retinopathy Market by Type, 2017 - 2020, USD Million
  • TABLE 30 Argentina Diabetic Retinopathy Market by Type, 2021 - 2027, USD Million
  • TABLE 31 Argentina Diabetic Retinopathy Market by Treatment Type, 2017 - 2020, USD Million
  • TABLE 32 Argentina Diabetic Retinopathy Market by Treatment Type, 2021 - 2027, USD Million
  • TABLE 33 UAE Diabetic Retinopathy Market, 2017 - 2020, USD Million
  • TABLE 34 UAE Diabetic Retinopathy Market, 2021 - 2027, USD Million
  • TABLE 35 UAE Diabetic Retinopathy Market by Type, 2017 - 2020, USD Million
  • TABLE 36 UAE Diabetic Retinopathy Market by Type, 2021 - 2027, USD Million
  • TABLE 37 UAE Diabetic Retinopathy Market by Treatment Type, 2017 - 2020, USD Million
  • TABLE 38 UAE Diabetic Retinopathy Market by Treatment Type, 2021 - 2027, USD Million
  • TABLE 39 Saudi Arabia Diabetic Retinopathy Market, 2017 - 2020, USD Million
  • TABLE 40 Saudi Arabia Diabetic Retinopathy Market, 2021 - 2027, USD Million
  • TABLE 41 Saudi Arabia Diabetic Retinopathy Market by Type, 2017 - 2020, USD Million
  • TABLE 42 Saudi Arabia Diabetic Retinopathy Market by Type, 2021 - 2027, USD Million
  • TABLE 43 Saudi Arabia Diabetic Retinopathy Market by Treatment Type, 2017 - 2020, USD Million
  • TABLE 44 Saudi Arabia Diabetic Retinopathy Market by Treatment Type, 2021 - 2027, USD Million
  • TABLE 45 South Africa Diabetic Retinopathy Market, 2017 - 2020, USD Million
  • TABLE 46 South Africa Diabetic Retinopathy Market, 2021 - 2027, USD Million
  • TABLE 47 South Africa Diabetic Retinopathy Market by Type, 2017 - 2020, USD Million
  • TABLE 48 South Africa Diabetic Retinopathy Market by Type, 2021 - 2027, USD Million
  • TABLE 49 South Africa Diabetic Retinopathy Market by Treatment Type, 2017 - 2020, USD Million
  • TABLE 50 South Africa Diabetic Retinopathy Market by Treatment Type, 2021 - 2027, USD Million
  • TABLE 51 Nigeria Diabetic Retinopathy Market, 2017 - 2020, USD Million
  • TABLE 52 Nigeria Diabetic Retinopathy Market, 2021 - 2027, USD Million
  • TABLE 53 Nigeria Diabetic Retinopathy Market by Type, 2017 - 2020, USD Million
  • TABLE 54 Nigeria Diabetic Retinopathy Market by Type, 2021 - 2027, USD Million
  • TABLE 55 Nigeria Diabetic Retinopathy Market by Treatment Type, 2017 - 2020, USD Million
  • TABLE 56 Nigeria Diabetic Retinopathy Market by Treatment Type, 2021 - 2027, USD Million
  • TABLE 57 Rest of LAMEA Diabetic Retinopathy Market, 2017 - 2020, USD Million
  • TABLE 58 Rest of LAMEA Diabetic Retinopathy Market, 2021 - 2027, USD Million
  • TABLE 59 Rest of LAMEA Diabetic Retinopathy Market by Type, 2017 - 2020, USD Million
  • TABLE 60 Rest of LAMEA Diabetic Retinopathy Market by Type, 2021 - 2027, USD Million
  • TABLE 61 Rest of LAMEA Diabetic Retinopathy Market by Treatment Type, 2017 - 2020, USD Million
  • TABLE 62 Rest of LAMEA Diabetic Retinopathy Market by Treatment Type, 2021 - 2027, USD Million
  • TABLE 63 Key Information - Alimera Sciences, Inc.
  • TABLE 64 KEY INFORMATION - F. HOFFMANN-LA ROCHE LTD.
  • TABLE 65 key information - Bausch Health Companies, Inc.
  • TABLE 66 Key Information - Bayer AG
  • TABLE 67 Key Information - Pfizer, Inc.
  • TABLE 68 Key Information - Novartis AG
  • TABLE 69 Key Information - Allergan PLC
  • TABLE 70 Key Information - Regeneron Pharmaceuticals, Inc.
  • TABLE 71 Key Information - Ampio Pharmaceuticals, Inc.
  • TABLE 72 Key Information - Kowa Company, Ltd.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Recent strategies and developments: Alimera Sciences, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!